Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Jill Foss Watson | CACC Credit Acceptance Corp | 13D/A | 14.1% | Mar 21, 2024 | 2y |
| BAKER BROS. ADVISORS LP | MDGL Madrigal Pharmaceuticals, Inc. | 13D/A | 9.99% | Mar 21, 2024 | 2y |
| ETFS Capital Limited. | WT WisdomTree, Inc. | 13D/A | 10% | Mar 21, 2024 | 2y |
| Redmile Group, LLC | FATE Fate Therapeutics Inc | 13D/A | 14.9% | Mar 21, 2024 | 2y |
| Samsara BioCapital, L.P. | LENZ LENZ Therapeutics, Inc. | 13G/A | 4.8% | Mar 21, 2024 | 2y |
| MEITAV INVESTMENT HOUSE LTD | FORTY Formula Systems (1985) Ltd | 13G/A | 5.01% | Mar 20, 2024 | 2y |
| Millennium Management LLC | MXCT Maxcyte, Inc. | 13G | 5.5% | Mar 19, 2024 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 7.2% | Mar 19, 2024 | 2y |
| FEDERATED HERMES, INC. | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13D | 12.65% | Mar 18, 2024 | 2y |
| Exor N.V. | NG Novagold Resources Inc | 13G | 5% | Mar 18, 2024 | 2y |
| Divisar Capital Management LLC | ADTN ADTRAN Holdings, Inc. | 13G | 5.5% | Mar 15, 2024 | 2y |
| AMR Action Fund, L.P. | HLSQ Tessera Defense & Homeland Security Inc. | 13G | 5.5% | Mar 15, 2024 | 2y |
| S.H.N. Financial Investments Ltd. | CISS C3is Inc. | 13G | 9.99% | Mar 15, 2024 | 2y |
| James J. Pallotta | AIRJ AirJoule Technologies Corp. | 13G | 7.15% | Mar 14, 2024 | 2y |
| CONTINENTAL GENERAL INSURANCE CO | DQ Daqo New Energy Corp. | 13G | 6.5% | Mar 14, 2024 | 2y |
| Jacob Shemer | PKBK Parke Bancorp, Inc. | 13D/A | 5.17% | Feb 28, 2024 | 2y |
| Mink Brook Asset Management LLC | STRR Star Equity Holdings, Inc. | 13G | 6.39% | Mar 22, 2024 | 2y |
| Investment Corporation of Dubai | NDAQ Nasdaq, Inc. | 13D/A | 10.1% | Mar 22, 2024 | 2y |
| ORBIMED ADVISORS LLC | CMPX Compass Therapeutics, Inc. | 13D/A | 13.7% | Mar 21, 2024 | 2y |
| Pfizer Inc | HLN Haleon plc | 13D/A | 22.6% | Mar 21, 2024 | 2y |
| Viessmann Generations Group GmbH & Co. KG | CARR CARRIER GLOBAL Corp | 13D/A | 6.53% | Mar 21, 2024 | 2y |
| Alibaba Group Holding Ltd | XPEV Xpeng Inc. | 13D/A | 4.9% | Mar 20, 2024 | 2y |
| The Donald A. Foss 2009 Remainder Trust | CACC Credit Acceptance Corp | 13D/A | 20.9% | Mar 20, 2024 | 2y |
| Hein Park Capital Management LP | DBD DIEBOLD NIXDORF, Inc | 13D/A | 8.15% | Mar 20, 2024 | 2y |
| Millstreet Capital Management LLC | DBD DIEBOLD NIXDORF, Inc | 13D/A | 17.24% | Mar 20, 2024 | 2y |
| ESL Partners, L.P. | AN Autonation, Inc. | 13D/A | 9.99% | Mar 20, 2024 | 2y |
| D. Kyle Cerminara | BKTI BK Technologies Corp | 13G | 5.9% | Mar 20, 2024 | 2y |
| Silver Lake Group, L.L.C. | DELL Dell Technologies Inc. | 13D/A | 21.7% | Mar 20, 2024 | 2y |
| Barry John F | PSEC Prospect Capital Corp | 13D/A | 26.25% | Mar 20, 2024 | 2y |
| Fortress Biotech, Inc. | CKPT Checkpoint Therapeutics, Inc. Common Stock | 13D/A | 7.5% | Mar 20, 2024 | 2y |
| Camac Partners, LLC | TSPH TuSimple Holdings Inc. | 13D/A | 5.1% | Mar 19, 2024 | 2y |
| THIRD AVENUE MANAGEMENT LLC | TPHS Trinity Place Holdings Inc. | 13D/A | 6.44% | Mar 18, 2024 | 2y |
| Deerfield Management Company, L.P. | HLSQ Tessera Defense & Homeland Security Inc. | 13D | 11.06% | Mar 15, 2024 | 2y |
| Headlands Capital Management, LLC | NDLS NOODLES & Co | 13D | 5.4% | Mar 15, 2024 | 2y |
| Deep Track Capital, LP | OLMA Olema Oncology, Inc. | 13G | 5.44% | Mar 14, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | AL SUMISHO AIR LEASE CORP | 13G | 0.2% | Mar 14, 2024 | 2y |
| Daniel Potter | XTIA XTI Aerospace, Inc. | 13G | 10.4% | Mar 12, 2024 | 2y |
| Nadav Kidron | ORMP Oramed Pharmaceuticals Inc. | 13D | 5.7% | Mar 6, 2024 | 2y |
| The ROP Revocable Trust dated 1/9/2018 | VTVT vTv Therapeutics Inc. | 13D/A | 50.3% | Feb 27, 2024 | 2y |
| Darren Maupin | SOC Sable Offshore Corp. | 13G | 12.6% | Feb 14, 2024 | 2y |
| WESTERLY CAPITAL MANAGEMENT, LLC | HHS Harte Hanks Inc | 13G/A | 9.66% | Dec 31, 2023 | 2y |
| Standard General L.P. | NCMI National CineMedia, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Starboard Value LP | AQN Algonquin Power & Utilities Corp. | 13D/A | 9% | Mar 21, 2024 | 2y |
| Sculptor Capital Management, Inc. | GROV Grove Collaborative Holdings, Inc. | 13D/A | 4.21% | Mar 20, 2024 | 2y |
| D. Kyle Cerminara | BKTI BK Technologies Corp | 13D/A | 6.7% | Mar 20, 2024 | 2y |
| Rosalind Advisors, Inc. | BFRI Biofrontera Inc. | 13G | 9.9% | Mar 20, 2024 | 2y |
| Joel E. Cutler | IOT Samsara Inc. | 13D/A | 12.61% | Mar 19, 2024 | 2y |
| ZUU Co. Ltd. | SBC SBC Medical Group Holdings Inc | 13D/A | 27.5% | Mar 19, 2024 | 2y |
| Fund 1 Investments, LLC | CTRN Citi Trends Inc | 13D/A | 19.4% | Mar 19, 2024 | 2y |
| ORBIMED ADVISORS LLC | ACET Adicet Bio, Inc. | 13D/A | 11.9% | Mar 19, 2024 | 2y |